Emergent BioSolutions
EBS
#6672
Rank
S$0.88 B
Marketcap
S$16.68
Share price
-2.99%
Change (1 day)
23.41%
Change (1 year)

Market capitalization of Emergent BioSolutions (EBS)

Market cap: S$0.88 Billion

As of January 2026 Emergent BioSolutions has a market cap of S$0.88 Billion. This makes Emergent BioSolutions the world's 6672th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Emergent BioSolutions from 2006 to 2026

End of year Market Cap

Year Marketcap Change
2026S$0.88 B4.51%
2025S$0.85 B39.79%
2024S$0.60 B270.37%
2023S$0.16 B-79.18%
2022S$0.78 B-75.02%
2021S$3.16 B-49.67%
2020S$6.28 B67.07%
2019S$3.76 B-9.31%
2018S$4.14 B33.71%
2017S$3.10 B61.11%
2016S$1.92 B-13.69%
2015S$2.23 B64.37%
2014S$1.35 B27.19%
2013S$1.06 B51.62%
2012S$0.70 B-10.27%
2011S$0.78 B-25.89%
2010S$1.05 B79.86%
2009S$0.58 B-47.35%
2008S$1.11 B415.76%
2007S$0.21 B-54.13%
2006S$0.47 B

End of Day market cap according to different sources

On Jan 9th, 2026 the market cap of Emergent BioSolutions was reported to be:

S$0.87 Billion
by Nasdaq info icon info icon
S$0.88 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Merck
MRK
S$355.28 B 39,828.83%๐Ÿ‡บ๐Ÿ‡ธ USA
SIGA Technologies
SIGA
S$0.60 B-31.54%๐Ÿ‡บ๐Ÿ‡ธ USA
GlaxoSmithKline
GSK
S$131.05 B 14,628.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
Celldex Therapeutics
CLDX
S$2.34 B 163.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$186.43 B 20,852.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
S$47.26 B 5,211.38%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Soligenix
SNGX
S$17.52 M-98.03%๐Ÿ‡บ๐Ÿ‡ธ USA